Low dosage of CBD may reduce seizures according to new study
Cannabidiol (CBD) was shown in a new large-scale, randomized, controlled trial to reduce the number of seizures in patients with a severe form of epilepsy called Lennox-Gastaut syndrome. The study was conducted with Epidiolex which is manufactured by GW Pharmaceuticals.